Form 4: Vita Coco Executive Chairman Sells Shares
Insider Stock Sale
Vita Coco Company Executive Chairman Michael Kirban sold 20,000 shares of common stock for approximately $39.045 per share under a Rule 10b5-1 trading plan.
Summary
- Michael Kirban, Executive Chairman of Vita Coco Company, Inc. (COCO), sold 20,000 shares of common stock.
- The transaction occurred on September 11, 2025, at a weighted average price of $39.045 per share, with individual sales ranging from $39.00 to $39.19.
- The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
- Following the sale, Kirban directly beneficially owns 127,629 shares of common stock.
- He also indirectly beneficially owns 1,579,049 shares through M. Kirban 2010 and 615,681 shares through the Michael Kirban Revocable Trust.
- Kirban holds various non-qualified stock options with exercise prices ranging from $10.178 to $32.78, totaling 1,065,790 underlying shares, some of which are fully vested and others vest in annual installments through March 2026.
Sentiment
Score: 5
Explanation: The filing reports an insider stock sale executed under a pre-arranged 10b5-1 plan, which is a routine disclosure and does not inherently indicate positive or negative sentiment about the company's future prospects.
Negatives
- The Executive Chairman's direct beneficial ownership of common stock decreased by 20,000 shares.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing is a routine insider transaction report and does not provide information directly related to broader industry trends or competitor performance.
Related Party Transactions
- Michael Kirban's indirect beneficial ownership includes shares held by M. Kirban 2010 and the Michael Kirban Revocable Trust.
Stakeholder Impact
- Shareholders: The Executive Chairman's direct ownership stake decreased, but the sale was pre-planned under a Rule 10b5-1 trading plan, which typically mitigates concerns about insider sentiment.
Key Dates
| Date | Description |
|---|---|
| November 27, 2022 | First vesting installment for 298,507 non-qualified stock options. |
| March 10, 2024 | First vesting installment for 46,875 non-qualified stock options. |
| March 4, 2025 | First vesting installment for 62,743 non-qualified stock options. |
| September 11, 2025 | Date of common stock transaction (sale of 20,000 shares). |
| September 15, 2025 | Signature date of the Form 4 filing. |
| March 3, 2026 | First vesting installment for 70,715 non-qualified stock options. |
| December 16, 2029 | Expiration date for 546,000 non-qualified stock options. |
| January 11, 2031 | Expiration date for 40,950 non-qualified stock options. |
| October 21, 2031 | Expiration date for 298,507 non-qualified stock options. |
| March 10, 2033 | Expiration date for 46,875 non-qualified stock options. |
| March 4, 2034 | Expiration date for 62,743 non-qualified stock options. |
| March 3, 2035 | Expiration date for 70,715 non-qualified stock options. |
Recommendation
holdThe filing details a pre-planned insider stock sale by the Executive Chairman, which is a routine disclosure and does not provide new fundamental information to alter an investment thesis. The sale was executed under a Rule 10b5-1 trading plan, indicating it was scheduled in advance and not necessarily based on new material non-public information.
Keywords
Vita Coco, COCO, Michael Kirban, Insider Transaction, Form 4, Stock Sale, 10b5-1 Plan, Executive Chairman, Beneficial Ownership, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.